4.7 Article

Mdm2-mediated ubiquitination of PKCβII in the nucleus mediates clathrin-mediated endocytic activity

期刊

BIOCHEMICAL PHARMACOLOGY
卷 170, 期 -, 页码 -

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2019.113675

关键词

PKC beta II; Ubiquitination; Mdm2; Clathrin-mediated endocytosis; Dopamine receptor

资金

  1. [KRF-2017R1A2A2A05001227]

向作者/读者索取更多资源

Cellular stimuli that increase diacylglycerol levels activate several protein kinase C (PKC) isoforms; however, prolonged stimulation depletes cells of PKCs. Ubiquitination is a critical cellular event that mediates the degradation of numerous proteins, including PKCs, but little is known of the molecular mechanisms involved in PKC ubiquitination. PKC beta II is the most widely expressed PKC isoform and regulates a variety of cellular functions. Here, we show that in response to stimulation of the Gq-coupled angiotensin II type 1 receptor or treatment with phorbol ester, Mdm2, E3 ubiquitin ligase, interacted with PKC beta II isotype in the nucleus, resulting in ubiquitination of PKC beta II at the C-terminal K668 and K672 residues and its subsequent downregulation. Ubiquitinated PKC beta II mediated the clathrin-mediated endocytosis of G protein-coupled receptors like the D-2 and D-3 dopamine receptors; in contrast, non-ubiquitinated PKC beta II mediated an as yet uncharacterized clathrin- and caveolar-independent endocytic pathway. In conclusion, we characterized the molecular mechanisms involved in the activity-dependent ubiquitination of PKC beta II that determine its life span and endocytic roles. Considering that PKC beta II plays an important role in the development of various diseases, including diabetic vasculitis, the results obtained in this study will contribute to better understanding the pathogenesis of PKC beta II-related diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据